ResMed CPAP Masks and Sleep Apnea Testing: A Procurement Manager's TCO View

I believe the cheapest CPAP mask is almost never the cheapest mask. That sounds like a riddle, but after seven years of buying sleep therapy supplies, I'm serious. I'm a procurement manager at a 40-person sleep clinic, and I've managed a consumables budget of roughly $320,000 a year. I've negotiated with 20+ vendors and tracked every order in our procurement system. In total cost terms, the mask that gets used beats the mask that gets stored every single time.

What is sleep apnea testing—and why it changes your mask buying

If you're new to this space, the first question is usually simple: what is sleep apnea testing? It's the diagnostic step that determines whether someone has obstructive sleep apnea. It used to mean an overnight stay in a clinic with wires and sensors (polysomnography). Increasingly, it's a home sleep apnea test (HSAT) that the patient uses in their own bed.

The test gives you a diagnosis and helps set therapy pressure. What it doesn't tell you is which mask the patient will tolerate at 3 a.m. That's where procurement gets complicated.

Argument 1: A mask that isn't worn is the most expensive option

ResMed is one of the most recognized CPAP brands in the world. When someone asks for CPAP ResMed masks, they usually mean the full lineup—nasal pillows, nasal masks, and full face masks. The AirTouch F20 full face mask ResMed offers is a good example. It's a full face mask with a memory-foam cushion, and it's one of our most reordered line items.

But a mask only works if a patient actually wears it. I learned this the hard way. I assumed a medium cushion would fit most adults. Didn't verify. Turned out nearly a third of our patients needed a large or a small, and we didn't stock either. Result: a messy week of expedited orders and a clinic full of frustrated staff.

Now, I'd rather pay slightly more for a mask system with multiple cushion sizes and a documented fit process. The extra cost per unit is tiny compared to the cost of a patient giving up on therapy.

Argument 2: Total cost is about the stack, not the sticker price

I keep a TCO spreadsheet. I started it after getting burned on hidden fees twice. Now I compare six layers: base product, headgear, cushion replacement interval, shipping, training, and the cost of a return.

Example: a vendor offered a low price on the AirTouch F20 full face mask. I said we need full face masks with headgear. They heard full face masks and quoted the mask alone. Result: no headgear, and we had to buy headgear separately for eighteen patients before we caught it.

This isn't a mask-specific problem. I've seen the same pattern with capital equipment. A lab director once chose a mass spectrometer because the quote was $12,000 below competing models. Then installation, training, and the service contract added $15,000 in costs by month nine. In the OR, surgical staplers seem like commodities—until the surgeon requests a specific reload and we don't have it. The cheapest quote is only the cheapest if every other cost is equal.

That's why I think in terms of total cost when I buy ResMed masks. I'd rather standardize on a platform with multiple cushion options and predictable delivery than chase the lowest per-unit price from an unknown vendor. (note to self: always confirm headgear is included in the mask SKU.)

Argument 3: The industry has evolved—and procurement should too

What was best practice in 2020 may not apply in 2025. The fundamentals haven't changed: a patient still needs a properly fitted mask to succeed on CPAP. But the execution has transformed. There are more mask sizes, more digital tracking, more remote patient monitoring, and more options for patient support.

Five years ago, our clinic ordered two sizes of full face mask and called it a day. Now we order multiple cushion sizes and track why patients adjust their therapy. This is progress, not a gimmick. But it also means a cost controller who only looks at unit price will make bad decisions.

Some skepticism about new mask designs is fair. I don't replace a workhorse product just because a sales rep has a slide deck. But I've learned to evaluate evidence, not marketing. Per FTC guidelines, marketing claims for medical products need to be truthful and substantiated. When a vendor says patients prefer this mask, ask for the study. If they can't produce it, that tells you something about the vendor.

Wait—shouldn't a procurement manager defend the lowest price?

I can hear the pushback: you manage a budget, your job is to reduce unit cost. I've heard that from my own finance team. They're not wrong about the line item; they're wrong about the outcome.

A lower unit price that increases non-compliance is not a saving. Replacing a machine early because a patient quit therapy is not a saving. Reordering because you stocked the wrong cushion is not a saving. I've made those mistakes. I still kick myself for not verifying the return policy on a trial order. If I'd asked what happens if the cushion doesn't fit, we'd have saved a month of inventory headaches.

Unit price matters. I compare three vendors minimum before I place a big order, and I keep a cost calculator so the finance team can see the full picture. But the goal is the lowest total cost of therapy, not the lowest cost of plastic.

My bottom line on ResMed CPAP masks

I get why people search for ResMed CPAP masks and look for the best price. I also get why sleep apnea testing is the starting point—without an accurate diagnosis, no mask will help. But the real cost control starts after the prescription. The mask that ends up in a drawer is the most expensive mask you can buy.

I don't buy the cheapest mask anymore. I buy the one that a patient is most likely to use, and I make sure the supply chain around it supports that choice. That might be an AirTouch F20 full face mask from ResMed, or it might be a different style entirely—the brand matters less than the fit.

In my experience, this approach has cut our return rate, reduced emergency reorders, and made my quarterly budget review a lot calmer. The price on the invoice matters. The price of a failed therapy matters more.